HGH Therapy

HGH (human growth hormone) is the actual hormone itself — injecting it directly introduces exogenous growth hormone into your body. Peptide secretagogues like sermorelin, CJC-1295, and ipamorelin are not growth hormone. They are signaling molecules that stimulate your pituitary gland to produce and release its own HGH naturally. Peptides preserve your body's natural feedback loop, produce a more physiological pattern of growth hormone release, and carry a lower risk of side effects. For most patients, peptides are the preferred first-line approach. Actual HGH is reserved for cases of documented GH deficiency or when peptides alone are insufficient.

HGH therapy is considered when you have symptoms of growth hormone deficiency — persistent fatigue, poor sleep quality, increased body fat (especially abdominal), loss of lean muscle, thinning skin, slow recovery from exercise or injury, and cognitive decline — combined with laboratory evidence of low IGF-1 levels. Not everyone with these symptoms needs HGH. We start with a comprehensive evaluation including blood work, and often trial growth hormone peptides first to see if your pituitary can be stimulated to produce adequate HGH on its own.

Yes, when prescribed by a licensed physician for a legitimate medical indication. HGH is FDA-approved for the treatment of adult growth hormone deficiency and other specific conditions. At Rewind Anti-Aging of Miami, HGH is prescribed based on documented clinical need — supported by symptoms, physical examination findings, and laboratory confirmation of deficiency. All prescriptions are dispensed through licensed pharmacies.

Common side effects include joint pain and stiffness (often dose-related and manageable by reducing the dose), mild fluid retention and swelling in the hands and feet, carpal tunnel syndrome symptoms, and headache. These side effects are typically dose-dependent — they tend to occur at higher doses and resolve when the dose is reduced. Rare but serious risks include elevated blood sugar, potential acceleration of pre-existing tumors, and intracranial hypertension. Proper medical supervision, appropriate dosing, and regular monitoring minimize these risks significantly.

Results occur in phases. Improved sleep quality is often the first benefit, noticed within the first one to two weeks. Increased energy, improved recovery from exercise, and better mood typically appear within the first one to two months. Body composition changes — reduced abdominal fat, increased lean muscle tone, improved skin quality and thickness — generally become visible between months three and six. The full spectrum of benefits continues to develop over six to twelve months of consistent therapy.

Not necessarily. Treatment duration depends on the cause and severity of your growth hormone deficiency. Some patients use HGH for a defined period — three to six months — to restore optimal levels, then transition to growth hormone peptides for maintenance. Others with more significant pituitary dysfunction may benefit from longer-term therapy. We reassess your IGF-1 levels, symptoms, and treatment goals at regular intervals to determine the optimal duration and whether a transition to peptide therapy is appropriate.